These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15664954)

  • 1. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition.
    Reckseidler-Zenteno SL; DeVinney R; Woods DE
    Infect Immun; 2005 Feb; 73(2):1106-15. PubMed ID: 15664954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.
    Woodman ME; Worth RG; Wooten RM
    PLoS One; 2012; 7(12):e52276. PubMed ID: 23251706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei.
    Reckseidler-Zenteno SL; Viteri DF; Moore R; Wong E; Tuanyok A; Woods DE
    J Med Microbiol; 2010 Dec; 59(Pt 12):1403-1414. PubMed ID: 20724509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants.
    Wikraiphat C; Charoensap J; Utaisincharoen P; Wongratanacheewin S; Taweechaisupapong S; Woods DE; Bolscher JG; Sirisinha S
    FEMS Immunol Med Microbiol; 2009 Aug; 56(3):253-9. PubMed ID: 19549172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.
    DeShazer D; Brett PJ; Woods DE
    Mol Microbiol; 1998 Dec; 30(5):1081-100. PubMed ID: 9988483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
    DeShazer D; Waag DM; Fritz DL; Woods DE
    Microb Pathog; 2001 May; 30(5):253-69. PubMed ID: 11373120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.
    Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC
    Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.
    Cuccui J; Milne TS; Harmer N; George AJ; Harding SV; Dean RE; Scott AE; Sarkar-Tyson M; Wren BW; Titball RW; Prior JL
    Infect Immun; 2012 Mar; 80(3):1209-21. PubMed ID: 22252864
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sharma S; Bhatnagar R; Gaur D
    Front Immunol; 2020; 11():462. PubMed ID: 32296419
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant.
    Reckseidler SL; DeShazer D; Sokol PA; Woods DE
    Infect Immun; 2001 Jan; 69(1):34-44. PubMed ID: 11119486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia pseudomallei Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis.
    Marchetti R; Dillon MJ; Burtnick MN; Hubbard MA; Kenfack MT; Blériot Y; Gauthier C; Brett PJ; AuCoin DP; Lanzetta R; Silipo A; Molinaro A
    ACS Chem Biol; 2015 Oct; 10(10):2295-302. PubMed ID: 26198038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosis.
    Gutierrez MG; Pfeffer TL; Warawa JM
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3441. PubMed ID: 25569630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudomonas pseudomallei and Pseudomonas mallei--capsule-forming bacteria].
    Popov SF; Kurilov VIa; Iakovlev AT
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):32-6. PubMed ID: 8525729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of a select agent-excluded Burkholderia pseudomallei capsule mutant in hamsters.
    Gutierrez MG; Warawa JM
    Acta Trop; 2016 May; 157():68-72. PubMed ID: 26836271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b.
    Masoud H; Ho M; Schollaardt T; Perry MB
    J Bacteriol; 1997 Sep; 179(18):5663-9. PubMed ID: 9294419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
    Kang WT; Vellasamy KM; Chua EG; Vadivelu J
    J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kingella kingae Surface Polysaccharides Promote Resistance to Human Serum and Virulence in a Juvenile Rat Model.
    Muñoz VL; Porsch EA; St Geme JW
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581191
    [No Abstract]   [Full Text] [Related]  

  • 18. Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages.
    Mulye M; Bechill MP; Grose W; Ferreira VP; Lafontaine ER; Wooten RM
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e2988. PubMed ID: 25144195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
    Warawa J; Woods DE
    FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection.
    Bayliss M; Donaldson MI; Nepogodiev SA; Pergolizzi G; Scott AE; Harmer NJ; Field RA; Prior JL
    Carbohydr Res; 2017 Nov; 452():17-24. PubMed ID: 29024844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.